Literature DB >> 15562596

Microbial adhesion of Cryptosporidium parvum sporozoites: purification of an inhibitory lipid from bovine mucosa.

Julie K Johnson1, Joann Schmidt, Howard B Gelberg, Mark S Kuhlenschmidt.   

Abstract

Cryptosporidium parvum is a protozoan pathogen of humans and livestock worldwide. Its ability to infect a wide range of species raises questions as to the involvement of a specific host cell receptor for parasite-host recognition. To investigate the mechanism of parasite-host cell recognition, we have developed an in vitro cell suspension binding assay to investigate adhesion of C. parvum sporozoites to host cells. Morphologic features of binding events observed with this assay were identical to those described in natural infections. Glycoconjugates, Madin Darby bovine kidney (MDBK) cell fractions, and plasma membrane vesicles (PMVs) were screened for their ability to block binding of sporozoites to MDBK cells. Mucins, MDBK cell fractions, and PMVs exhibited dose-dependent inhibition of sporozoite binding. The major inhibitory fraction from MDBK cells was found to be insoluble in aqueous medium, nonsaponifiable, and lacking carbohydrate moieties, nitrogen, and phosphorus. Its inhibitory effect was resistant to heat, protease digestion, and glycosidase treatment, suggesting that the inhibitory activity is a lipid or a lipid-like component. The inhibitory activity was purified from MDBK cells, and in larger amounts from bovine small intestinal mucosa, by organic solvent extraction, semipreparative high-pressure liquid chromatography, and preparative high-performance thin-layer chromatography. Biochemical analyses, thin-layer chromatography staining techniques, mass spectrometry, and elemental analysis were used to partially characterize the purified lipid. These results indicate that a host intestinal lipid(s) or a lipid-like component(s) may play an important role in the early stages of host cell invasion by C. parvum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15562596      PMCID: PMC2579925          DOI: 10.1645/GE-231R

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  32 in total

1.  Freeze-fracture study of the site of attachment of Cryptosporidium muris in gastric glands.

Authors:  H Yoshikawa; M Iseki
Journal:  J Protozool       Date:  1992 Sep-Oct

2.  Plasma membrane vesiculation: a new technique for isolation of plasma membranes.

Authors:  R E Scott
Journal:  Science       Date:  1976-11-12       Impact factor: 47.728

Review 3.  Cryptosporidium spp. and cryptosporidiosis.

Authors:  R Fayer; B L Ungar
Journal:  Microbiol Rev       Date:  1986-12

4.  Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue culture cells.

Authors:  R Lumb; K Smith; P J O'Donoghue; J A Lanser
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

5.  Toxoplasma gondii stimulates the release of 13- and 9-hydroxyoctadecadienoic acids by human platelets.

Authors:  W R Henderson; M Rashed; E C Yong; T R Fritsche; G K Chiang
Journal:  Biochemistry       Date:  1992-06-16       Impact factor: 3.162

6.  Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission.

Authors:  W L Current; N C Reese; J V Ernst; W S Bailey; M B Heyman; W M Weinstein
Journal:  N Engl J Med       Date:  1983-05-26       Impact factor: 91.245

7.  Cryptosporidiosis in man: parasite life cycle and fine structural pathology.

Authors:  R G Bird; M D Smith
Journal:  J Pathol       Date:  1980-11       Impact factor: 7.996

8.  A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice.

Authors:  W L Current; N C Reese
Journal:  J Protozool       Date:  1986-02

9.  Cryptosporidiosis in immunocompetent patients.

Authors:  J S Wolfson; J M Richter; M A Waldron; D J Weber; D M McCarthy; C C Hopkins
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

10.  Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane.

Authors:  E C Yong; E Y Chi; T R Fritsche; W R Henderson
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  3 in total

1.  Microbial adhesion of Cryptosporidium parvum: identification of a colostrum-derived inhibitory lipid.

Authors:  Joann Schmidt; Mark S Kuhlenschmidt
Journal:  Mol Biochem Parasitol       Date:  2008-07-15       Impact factor: 1.759

2.  Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.

Authors:  Theresa B Kuhlenschmidt; Florentine U Rutaganira; Shaojun Long; Keliang Tang; Kevan M Shokat; Mark S Kuhlenschmidt; L David Sibley
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

Review 3.  Treatment of calf diarrhea: antimicrobial and ancillary treatments.

Authors:  Peter D Constable
Journal:  Vet Clin North Am Food Anim Pract       Date:  2009-03       Impact factor: 3.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.